当前位置:首页 - 行情中心 - 昆药集团(600422) - 财务分析 - 现金流量表

昆药集团

(600422)

  

流通市值:65.86亿  总市值:65.86亿
流通股本:7.57亿   总股本:7.57亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金860,540,950.227,160,380,415.165,438,368,562.353,789,337,884.73
  收到的税费返还1,795,801.1213,293,571.825,920,295.844,626,766.56
  收到其他与经营活动有关的现金27,984,200.79326,873,047.1212,104,505.34192,196,783.54
  经营活动现金流入小计890,320,952.137,500,547,034.085,656,393,363.533,986,161,434.83
  购买商品、接受劳务支付的现金801,950,371.793,744,966,808.882,887,469,504.62,022,292,823.6
  支付给职工以及为职工支付的现金242,333,033.06811,455,837.84623,827,170.27438,823,095.97
  支付的各项税费111,277,367.14564,410,153.72501,768,910.02332,396,668.65
  支付其他与经营活动有关的现金348,448,969.862,090,478,130.841,467,164,111.4973,817,890.26
  经营活动现金流出小计1,504,009,741.857,211,310,931.285,480,229,696.293,767,330,478.48
  经营活动产生的现金流量净额-613,688,789.72289,236,102.8176,163,667.24218,830,956.35
二、投资活动产生的现金流量:
  收回投资收到的现金809,087,644.85,309,344,025.762,611,402,378.591,288,418,692.36
  取得投资收益收到的现金3,559,219.3330,030,603.5531,314,002.635,302,749.06
  处置固定资产、无形资产和其他长期资产收回的现金净额395,677.591,781,068.271,129,438.081,120,845.54
  处置子公司及其他营业单位收到的现金净额-4,100,683.22--
  投资活动现金流入小计813,042,541.725,345,256,380.82,643,845,819.31,294,842,286.96
  购建固定资产、无形资产和其他长期资产支付的现金32,294,992.0190,559,480.9758,025,860.5426,325,967.73
  投资支付的现金811,000,0005,891,700,0004,060,700,0002,630,700,000
  投资活动现金流出小计843,294,992.015,982,259,480.974,118,725,860.542,657,025,967.73
  投资活动产生的现金流量净额-30,252,450.29-637,003,100.17-1,474,880,041.24-1,362,183,680.77
三、筹资活动产生的现金流量:
  吸收投资收到的现金-16,000,000--
  其中:子公司吸收少数股东投资收到的现金-16,000,000--
  取得借款收到的现金241,761,560.451,740,208,570.611,392,199,133.631,253,539,493.46
  筹资活动现金流入小计241,761,560.451,756,208,570.611,392,199,133.631,253,539,493.46
  偿还债务支付的现金322,737,897.8853,059,676.43505,569,385.28348,496,701.78
  分配股利、利润或偿付利息支付的现金8,975,445.1280,061,700.27258,056,625.1222,152,893.16
  支付其他与筹资活动有关的现金5,896,035.331,277,722,717.79742,386,933.71729,282,140.27
  筹资活动现金流出小计337,609,378.232,410,844,094.491,506,012,944.111,099,931,735.21
  筹资活动产生的现金流量净额-95,847,817.78-654,635,523.88-113,813,810.48153,607,758.25
四、汇率变动对现金及现金等价物的影响-1,835,325.48-534,546.4711,822.521,028,421.12
五、现金及现金等价物净增加额-741,624,383.27-1,002,937,067.65-1,411,818,361.96-988,716,545.05
  加:期初现金及现金等价物余额1,130,987,344.122,133,924,411.772,133,924,411.772,133,924,411.77
  期末现金及现金等价物余额389,362,960.851,130,987,344.12722,106,049.811,145,207,866.72
补充资料:
  净利润-419,052,861.68-249,920,820.76
  资产减值准备-31,589,763.74-4,752,967.11
  固定资产和投资性房地产折旧-110,268,016.18-55,206,137.69
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-110,268,016.18-55,206,137.69
  无形资产摊销-56,275,723.24-28,142,459.46
  长期待摊费用摊销-8,232,412.94-3,872,144.43
  处置固定资产、无形资产和其他长期资产的损失--673,035.91-757.86
  固定资产报废损失--499,982.83--496,561.76
  公允价值变动损失--108,913,808.46--1,445,663.76
  财务费用-50,581,519.23-27,472,873.34
  投资损失--62,011,166.44-694,593.72
  递延所得税-41,962,629.53--29,230,675.45
  其中:递延所得税资产减少-41,972,468.58--27,995,899.32
    递延所得税负债增加--9,839.05--1,234,776.13
  存货的减少-149,981,602.92-78,098,571.92
  经营性应收项目的减少-345,144,197.15-182,962,263.19
  经营性应付项目的增加--801,271,508.47--400,859,574.05
  不涉及现金收支的投资和筹资活动金额其他项目-1,039,406,968.4--
  现金的期末余额-1,130,987,344.12-1,090,511,562.96
  减:现金的期初余额-2,133,924,411.77-2,133,924,411.77
  加:现金等价物的期末余额---54,696,303.76
  现金及现金等价物的净增加额--1,002,937,067.65--988,716,545.05
公告日期2026-04-252026-03-202025-10-252025-08-16
审计意见(境内)标准无保留意见
TOP↑